Status:

COMPLETED

Dexmedetomidine and Fentanyl as Adjuvants to Thoracic Epidural

Lead Sponsor:

Cairo University

Conditions:

Post-operative Pain

Thoracic Epidural

Eligibility:

All Genders

18-60 years

Phase:

NA

Brief Summary

To find out if there is a benefit from adding dexmedetomidine to epidural bupivacaine as regards: * Intra and postoperative opioid consumption * Pain score (numerical rating scale) * Hemodynamic stab...

Detailed Description

Following approval from Research Committee of Anesthesia Department and the Ethics Committee of the Faculty of Medicine, Cairo University, 50 patients will be included in the study (25 patients per gr...

Eligibility Criteria

Inclusion

  • Age 18 - 60 years old
  • ASA physical status I-II-III
  • Good mental function.
  • Patient scheduled for thoracic surgery with posterolateral thoracotomy.
  • BMI of patient (18 - 30).

Exclusion

  • Age less than 18 or more than 60 years old
  • Any contraindications to epidural injection (patient refusal, local infection at the site of injection, coagulopathy, patients on anticoagulant or antiplatelet drugs, known allergy to local anesthetics, significant spine deformity)
  • Inability to provide informed consent or pain score

Key Trial Info

Start Date :

January 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 29 2024

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06489574

Start Date

January 1 2023

End Date

February 29 2024

Last Update

July 8 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Faculty of Medicine, Cairo University

Cairo, Egypt